NDC Product
Human Prescription DrugPancreaze NDC 62541-401
- Generic Name
- Pancrelipase Lipase, Pancrelipase Amylase, And Pancrelipase Protease
- Dosage Form
- Capsule, Delayed Release
- Route
- Oral
- Marketing
- BLA
Active Listing
Lipase 4200 UNT / amylase 24,600 UNT / protease 14,200 UNT Delayed Release Oral Capsule
RxNorm 1806964 NDC Crossover
NDC Directory Crossover & Product Mapping
The following National Drug Codes (NDCs) are directly associated with the clinical concept for Lipase 4200 UNT / amylase 24,600 UNT / protease 14,200 UNT Delayed Release Oral Capsule (RxCUI 1806964). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.
Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.
